Bausch Health Cos Total Long-Term Assets 2010-2024 | BHC

Bausch Health Cos total long-term assets from 2010 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
Bausch Health Cos Annual Total Long-Term Assets
(Millions of US $)
2023 $21,754
2022 $21,439
2021 $23,595
2020 $25,857
2019 $26,894
2018 $28,281
2017 $32,751
2016 $38,452
2015 $43,458
2014 $22,173
2013 $24,085
2012 $15,173
2011 $11,751
2010 $9,775
2009 $1,716
Bausch Health Cos Quarterly Total Long-Term Assets
(Millions of US $)
2024-09-30 $21,189
2024-06-30 $21,284
2024-03-31 $21,517
2023-12-31 $21,754
2023-09-30 $22,016
2023-06-30 $21,042
2023-03-31 $21,208
2022-12-31 $21,439
2022-09-30 $22,288
2022-06-30 $22,754
2022-03-31 $23,254
2021-12-31 $23,595
2021-09-30 $23,928
2021-06-30 $24,592
2021-03-31 $24,805
2020-12-31 $25,857
2020-09-30 $25,891
2020-06-30 $26,118
2020-03-31 $26,361
2019-12-31 $26,894
2019-09-30 $27,362
2019-06-30 $27,887
2019-03-31 $28,276
2018-12-31 $28,281
2018-09-30 $29,035
2018-06-30 $29,809
2018-03-31 $31,074
2017-12-31 $32,751
2017-09-30 $34,030
2017-06-30 $35,741
2017-03-31 $37,000
2016-12-31 $38,452
2016-09-30 $40,087
2016-06-30 $41,844
2016-03-31 $42,786
2015-12-31 $43,458
2015-09-30 $41,459
2015-06-30 $41,998
2015-03-31 $22,374
2014-12-31 $22,173
2014-09-30 $22,646
2014-06-30 $22,732
2014-03-31 $24,039
2013-12-31 $24,085
2013-09-30 $24,356
2013-06-30 $15,250
2013-03-31 $15,116
2012-12-31 $15,173
2012-09-30 $12,433
2012-06-30 $12,390
2012-03-31 $12,088
2011-12-31 $11,751
2011-09-30 $10,719
2011-06-30 $10,782
2011-03-31 $10,413
2010-12-31 $9,775
2010-09-30 $9,835
2010-06-30 $1,615
2010-03-31 $1,666
2009-12-31 $1,716
2009-09-30 $1,634
2009-06-30 $1,679
2009-03-31 $948
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $3.009B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.350B 6.35
Dr Reddy's Laboratories (RDY) India $11.677B 22.35
BridgeBio Pharma (BBIO) United States $4.392B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.142B 12.88
Supernus Pharmaceuticals (SUPN) United States $1.978B 26.93
Taysha Gene Therapies (TSHA) United States $0.447B 31.14
Personalis (PSNL) United States $0.239B 0.00
Assembly Biosciences (ASMB) United States $0.094B 0.00
Sol-Gel Technologies (SLGL) Israel $0.013B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00
Teligent (TLGT) United States $0.000B 0.00